American Journal of Roentgenology, Vol 165, 627-631, Copyright © 1995 by American Roentgen Ray Society

ARTICLES

Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases

RB Schwartz, SM Bravo, RA Klufas, L Hsu, PD Barnes, CD Robson and JH Antin
Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA.

OBJECTIVE. The neurotoxic effects of cyclosporine therapy are well known but poorly understood. Imaging studies typically show subcortical edema predominantly affecting the posterior regions of the brain. We sought to determine the causes for these findings by comparing radiographic data with various clinical parameters. MATERIALS AND METHODS. In a 3-year period, 16 patients with neurologic findings attributed to cyclosporine therapy were examined with CT, MR imaging, or both. In most cases, imaging was performed both at the onset of the neurologic syndrome and after it had resolved. The radiographic findings were evaluated with respect to lesion location and changes over time. Various clinical and laboratory data obtained throughout the patients' hospital course were also reviewed, including cyclosporine levels, blood pressure values, hematologic data, and serum levels of cholesterol, magnesium, creatinine, and albumin. RESULTS. The only major factor associated with the neurotoxic effects of cyclosporine in all patients was systemic hypertension. Microangiopathic hemolytic anemia, thrombocytopenia, and hypoalbuminemia were also common, and patients usually displayed signs of sympathetic overactivation. The onset of neurologic symptoms was unrelated to serum levels of creatinine, magnesium, cholesterol, or cyclosporine. The clinical and radiographic findings of these patients were identical to those previously reported in patients with hypertensive encephalopathy. Findings resolved in all but one patient after reduction of blood pressure, with or without reduction in cyclosporine dose. In four patients, intracranial hemorrhages occurred during the hypertensive episode, resulting in one fatality. CONCLUSION. The clinical and radiologic findings in patients showing the neurotoxic effects of cyclosporine appear to be identical to those with hypertensive encephalopathy. Other associated factors, such as cyclosporine-induced vasculopathy or hypoalbuminemia may also play a role in the condition, and intracranial hemorrhage may occur owing to associated thrombocytopenia. Symptoms generally resolve after reduction of blood pressure, and follow-up is usually unnecessary in uncomplicated cases.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Ishikura, M. Ikeda, Y. Hamasaki, H. Hataya, G. Nishimura, R. Hiramoto, and M. Honda Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2531 - 2536. [Abstract] [Full Text] [PDF]

				W.S. Bartynski Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1036 - 1042. [Abstract] [Full Text] [PDF]

				W.S. Bartynski Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1043 - 1049. [Abstract] [Full Text] [PDF]

				W.S. Bartynski, H.P. Tan, J.F. Boardman, R. Shapiro, and J.W. Marsh Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 924 - 930. [Abstract] [Full Text] [PDF]

				C GURSES, A DURUKAN, S SENCER, S AKCA, B BAYKAN, and A GOKYIGIT A severe neurological sequela in acute intermittent porphryria: presentation of a case from encephalopathy to quadriparesis Br. J. Radiol., May 1, 2008; 81(965): e135 - e140. [Abstract] [Full Text] [PDF]

				V. H. Lee, E. F. M. Wijdicks, E. M. Manno, and A. A. Rabinstein Clinical Spectrum of Reversible Posterior Leukoencephalopathy Syndrome Arch Neurol, February 1, 2008; 65(2): 205 - 210. [Abstract] [Full Text] [PDF]

				A. M. McKinney, J. Short, C. L. Truwit, Z. J. McKinney, O. S. Kozak, K. S. SantaCruz, and M. Teksam Posterior Reversible Encephalopathy Syndrome: Incidence of Atypical Regions of Involvement and Imaging Findings Am. J. Roentgenol., October 1, 2007; 189(4): 904 - 912. [Abstract] [Full Text] [PDF]

				W.S. Bartynski and J.F. Boardman Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy Syndrome AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1320 - 1327. [Abstract] [Full Text] [PDF]

				M. J. Cipolla Cerebrovascular Function in Pregnancy and Eclampsia Hypertension, July 1, 2007; 50(1): 14 - 24. [Full Text] [PDF]

				N Prasad, S Gulati, R K Gupta, K Sharma, K Gulati, R K Sharma, and A Gupta Spectrum of radiological changes in hypertensive children with reversible posterior leucoencephalopathy Br. J. Radiol., June 1, 2007; 80(954): 422 - 429. [Abstract] [Full Text] [PDF]

				J. L. Taylor and S. M. Palmer Critical Care Perspective on Immunotherapy in Lung Transplantation J Intensive Care Med, December 1, 2006; 21(6): 327 - 344. [Abstract] [PDF]

				W.S. Bartynski, J.F. Boardman, Z.R. Zeigler, R.K. Shadduck, and J. Lister Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2179 - 2190. [Abstract] [Full Text] [PDF]

				H. Ozyurek, G. Oguz, S. Ozen, C. Akyuz, K. K. Oguz, B. Anlar, and S. Aysun Reversible Posterior Leukoencephalopathy Syndrome: Report of Three Cases J Child Neurol, December 1, 2005; 20(12): 990 - 993. [Abstract] [PDF]

				N. Besenski, Z. Rumboldt, O. Emovon, J. Nicholas, S. Kini, J. Milutinovic, and M. N. Budisavljevic Brain MR Imaging Abnormalities in Kidney Transplant Recipients AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2282 - 2289. [Abstract] [Full Text] [PDF]

				N. J. Serkova, U. Christians, and L. Z. Benet Biochemical Mechanisms of Cyclosporine Neurotoxicity Mol. Interv., April 1, 2004; 4(2): 97 - 107. [Abstract] [Full Text] [PDF]

				W. S. Bartynski, Z. R. Zeigler, R. K. Shadduck, and J. Lister Pretransplantation Conditioning Influence on the Occurrence of Cyclosporine or FK-506 Neurotoxicity in Allogeneic Bone Marrow Transplantation AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 261 - 269. [Abstract] [Full Text] [PDF]

				K J Ahn, J W Lee, S T Hahn, D W Yang, P S Kim, H J Kim, and C C Kim Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity Br. J. Radiol., December 1, 2003; 76(912): 916 - 919. [Abstract] [Full Text] [PDF]

				J.-T. Lin, S.-J. Wang, J.-L. Fuh, L.-T. Hsiao, J.-F. Lirng, and P.-M. Chen Prolonged Reversible Vasospasm in Cyclosporin A-Induced Encephalopathy AJNR Am. J. Neuroradiol., January 1, 2003; 24(1): 102 - 104. [Abstract] [Full Text] [PDF]

				S C Keswani and R Wityk Don't throw in the towel! A case of reversible coma J. Neurol. Neurosurg. Psychiatry, July 1, 2002; 73(1): 83 - 84. [Abstract] [Full Text] [PDF]

				D. J. Covarrubias, P. H. Luetmer, and N. G. Campeau Posterior Reversible Encephalopathy Syndrome: Prognostic Utility of Quantitative Diffusion-Weighted MR Images AJNR Am. J. Neuroradiol., June 1, 2002; 23(6): 1038 - 1048. [Abstract] [Full Text] [PDF]

				W. S. Bartynski, Z. Zeigler, M. P. Spearman, L. Lin, R. K. Shadduck, and J. Lister Etiology of Cortical and White Matter Lesions in Cyclosporin-A and FK-506 Neurotoxicity AJNR Am. J. Neuroradiol., November 1, 2001; 22(10): 1901 - 1914. [Abstract] [Full Text] [PDF]

				N. L. Antunes Topical Review: Acute Neurologic Complications in Children With Systemic Cancer J Child Neurol, November 1, 2000; 15(11): 705 - 716. [Abstract] [PDF]

				R. B. Schwartz, S. K. Feske, J. F. Polak, U. DeGirolami, A. Iaia, K. M. Beckner, S. M. Bravo, R. A. Klufas, R. Y. C. Chai, and J. T. Repke Preeclampsia-Eclampsia: Clinical and Neuroradiographic Correlates and Insights into the Pathogenesis of Hypertensive Encephalopathy Radiology, November 1, 2000; 217(2): 371 - 376. [Abstract] [Full Text]

				S. O. Casey, R. C. Sampaio, E. Michel, and C. L. Truwit Posterior Reversible Encephalopathy Syndrome: Utility of Fluid-attenuated Inversion Recovery MR Imaging in the Detection of Cortical and Subcortical Lesions AJNR Am. J. Neuroradiol., July 1, 2000; 21(7): 1199 - 1206. [Abstract] [Full Text] [PDF]

				N. Bargalló, M. Burrel, J. Berenguer, F. Cofan, L. Buñesch, and J. M. Mercader Cortical Laminar Necrosis Caused by Immunosuppressive Therapy and Chemotherapy AJNR Am. J. Neuroradiol., March 1, 2000; 21(3): 479 - 484. [Abstract] [Full Text]

				M. J. Cooney, W. G. Bradley, S. C. Symko, S. T. Patel, and P. K. Groncy Hypertensive Encephalopathy: Complication in Children Treated for Myeloproliferative Disorders-Report of Three Cases Radiology, March 1, 2000; 214(3): 711 - 716. [Abstract] [Full Text]

				J. M. Provenzale CT and MR Imaging of Nontraumatic Neurologic Emergencies Am. J. Roentgenol., February 1, 2000; 174(2): 289 - 299. [Full Text] [PDF]

				M. Wong, G. B. Mallory Jr., J. Goldstein, M. Goyal, and K. A. Yamada Neurologic complications of pediatric lung transplantation Neurology, October 1, 1999; 53(7): 1542 - 1542. [Abstract] [Full Text]

				S. C. Coley, D. A. Porter, F. Calamante, W. K. Chong, and A. Connelly Quantitative MR Diffusion Mapping and Cyclosporine-Induced Neurotoxicity AJNR Am. J. Neuroradiol., September 1, 1999; 20(8): 1507 - 1510. [Abstract] [Full Text]

				T. Sheth, Ichise, and Kucharczyk Brain Perfusion Imaging in Asymptomatic Patients Receiving AJNR Am. J. Neuroradiol., May 1, 1999; 20(5): 853 - 856. [Abstract] [Full Text]

				N. Serkova, L. Litt, T. L. James, W. Sadée, D. Leibfritz, L. Z. Benet, and U. Christians Evaluation of Individual and Combined Neurotoxicity of the Immunosuppressants Cyclosporine and Sirolimus by In Vitro Multinuclear NMR Spectroscopy J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 800 - 806. [Abstract] [Full Text]

				S. G. Pavlakis, Y. Frank, and R. Chusid Topical Review: Hypertensive Encephalopathy, Reversible Occipitoparietal Encephalopathy, or Reversible Posterior Leukoencephalopathy: Three Names for an Old Syndrome J Child Neurol, May 1, 1999; 14(5): 277 - 281. [Abstract] [PDF]

				J. G. Gleeson, A. J. duPlessis, P. D. Barnes, and J. J. Riviello Jr Cyclosporin A Acute Encephalopathy and Seizure Syndrome in Childhood: Clinical Features and Risk of Seizure Recurrence J Child Neurol, July 1, 1998; 13(7): 336 - 344. [Abstract] [PDF]

				R. B. Schwartz, J. M. Eaton, E. P.J. Arnoldus, T. Van Laar, J. S. Kahn, S. Romano, W. A. Andiman, J. Hinchey, and L. R. Caplan A Reversible Posterior Leukoencephalopathy Syndrome N. Engl. J. Med., June 27, 1996; 334(26): 1743 - 1746. [Full Text]